The incorporation of income and leisure in health state valuations when the measure is silent: An empirical inquiry into the sound of silence

Medical Decision Making

Volumn 29, Issue 4, 2009, Pages 503-512

  Brouwer, Werner B F ^a,c   Grootenboer, Saskia ^a   Sendi, Pedram ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Health state valuation; Leisure; Productivity costs; Valuation.

Indexed keywords

ARTICLE; CONVENIENCE SAMPLE; COST; COST EFFECTIVENESS ANALYSIS; EMPIRICISM; HEALTH STATUS; INCOME; LEISURE; PRODUCTIVITY; VISUAL ANALOG SCALE; ADULT; COMPARATIVE STUDY; CONFIDENCE INTERVAL; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HEALTH STATUS INDICATOR; HUMAN; MALE; MULTIVARIATE ANALYSIS; NETHERLANDS; PAIN MEASUREMENT; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA;

ADULT; CONFIDENCE INTERVALS; COST-BENEFIT ANALYSIS; EFFICIENCY; FEMALE; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; INCOME; LEISURE ACTIVITIES; MALE; MULTIVARIATE ANALYSIS; NETHERLANDS; PAIN MEASUREMENT; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 68349128086     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X09336161     Document Type: Article

References (19)

1. Rothermich EA, Pathak DS Productivity-cost controversies in cost-effectiveness analysis: review and research agenda. Clin Ther. 1999 ; 21: 255-67.
2. Sculpher M. The role and estimation of productivity costs in economic evaluation. In: Drummond MF, McGuire A, eds. Economic Evaluation in Health Care: Merging Theory with Practice. Oxford, UK: Oxford University Press ; 2001. p 94-112.
3. Sculpher MJ, O'Brien BJ Income effects of reduced health and health effects of reduced income: implications for health-state valuation. Med Decis Making. 2000 ; 20 (2). 207-15.
4. Brouwer WBF, Rutten FTH. The missing link: on the line between C and E. Health Econ. 2003 ; 12: 629-36.
5. Brouwer WBF, Koopmanschap MA, Rutten FTH. Patient and informal caregiver time in cost-effectiveness analysis: a response to the recommendations of the Washington Panel. Int J Technol Assess Health Care. 1998 ; 14: 505-13.
6. Sendi P., Brouwer WBF. Leisure time in economic evaluation: theoretical and practical considerations. Expert Rev Pharmacoecon Outcomes Res 2004 ; 4: 1-4.
7. Johannesson M. Avoiding double-counting in pharmacoeconomic studies. Pharmacoeconomics. 1997 ; 11: 385-88.
8. Gold MR, Siegel JE, Russell LB, Weinstein MC Cost-Effectiveness in Health and Medicine. Oxford, UK: Oxford University Press; 1996.
9. Brouwer WBF, Koopmanschap MA, Rutten FTH. Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel. Health Econ. 1997 ; 6: 253-9.
10. Brouwer WBF, Koopmanschap MA, Rutten FFH. Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion. Health Econ. 1997 ; 6: 511-14.
11. Meltzer D., Johannesson M. Inconsistencies in the ''societal perspective'' on costs of the Panel on Cost-Effectiveness in Health and Medicine. Med Decis Making. 1999 ; 19: 371-77.
12. Weinstein MC, Siegel JE, Garber AM, et al. Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group. Health Econ. 1997 ; 6: 505-10.
13. Meltzer DO, Weckerle CE, Chang LM Do people consider financial effects in answering quality of life questions ? Med Decis Making. 1999 ; 19: 517.
14. Sendi P., Brouwer WBF. Is silence golden? A test of the incorporation of the effects of ill-health on income and leisure in health state valuations. Health Econ. 2005 ; 14: 643-47.
15. Krol M., Brouwer WBF, Sendi P. The incorporation of income in health state valuations. Does explicit instruction matter? Pharmacoeconomics. 2006 ; 24 (4). 401-14.
16. Myers J., McCabe S., Gohmann S. Quality-of-life assessment when there is a loss of income. Med Decis Making. 2007 ; 27 (1). 27-33.
17. Torrance GW, Feeny D., Furlong W. Visual analogue scales: do they have a role in the measurement of preferences for health states ? Med Decis Making. 2001 ; 21: 329-34.
18. Parkin D., Devlin N. Is there a case for using visual analogue scale valuations in cost-utility analysis ? Health Econ. 2006 ; 15 (7). 653-64.
19. Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997 ; 35 (11). 1095-108.